Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Extracellular Vesicles May Play an Important Role in Seropositive RA Disease Severity

Lara C. Pullen, PhD  |  February 21, 2019

Patients with rheumatoid arthritis (RA) have systemic inflammation characterized by a distinct pattern of circulating cytokines and chemokines. Example: Joint destruction in RA patients is associated with elevated levels of proinflammatory cytokines, as well as CD16+ monocytes in the synovial fluid. Circulating cytokines and altered extracellular vesicles can affect adipose, skeletal muscle, liver and vascular endothelium. Previous studies have shown that, in vitro, extracellular vesicles immune complexes can cause neutrophils to upregulate production of leukotriene B4.

Recent research demonstrates that extracellular vesicles from seropositive RA patients can activate mononuclear phagocytes in vitro. Catalina Burbano, PhD, a researcher at the Universidad de Antioquia, Colombia, and colleagues found extracellular vesicles from seropositive patients could also induce in vitro proinflammatory cytokines that replicated the inflammatory response observed in these patients at the systemic level. The results, published online in Scientific Reports, suggest extracellular vesicles may contribute to the greater disease severity typically seen in patients with seropositive RA.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators examined RA patients, finding they had distinct profiles of circulating components, such as cytokines, extracellular vesicles and monocyte subsets, based on their antibody status. Seropositive patients had altered counts and receptor expression of intermediate monocytes, as well as extracellular vesicles immune complexes+ and extracellular vesicles citrullinated peptides+. Seropositive patients also had increased levels of proinflammatory cytokines interleukin (IL) 1β, IL-6 and tumor necrosis factor-alpha, relative to seronegative patients and healthy controls. The researchers found this systemic inflammatory profile was unrelated to disease activity.

“Our results suggest systemic inflammatory process does not always coincide with articular inflammation, as shown by the weak association between circulating cytokines and DAS28 [disease activity score 28],” write the authors in their discussion. “This [finding] suggests classifying the disease as active based only on the articular commitment of DAS28 is insufficient to determine individuals with systemic and non-joint inflammation. In addition, we observed not all patients with high DAS28 exhibited high levels of circulating inflammatory cytokines.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers discovered that circulating and synovial fluid extracellular vesicles from patients with RA were highly heterogeneous in size and larger than those from healthy controls. They also found platelets were the most frequent source of extracellular vesicles in RA patients. When researchers examined the extracellular vesicles of seropositive patients and compared them with those of seronegative patients, they found seropositive patients had higher frequencies of circulating extracellular vesicles that were positive for IgG, IgM, CD41a and citrulline. However, the investigators did not see similar alterations in seronegative patients whose inflammation profile was more similar to healthy controls. When the researchers compared seropositive patients with healthy controls, they saw a significant decrease in extracellular vesicles CD14+.


Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

  1. Burbano C, Rojas M, Muñoz-Vahos C, et al. Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis. Sci Rep. 2018 Dec 17;8(1):17917.

Page: 1 2 | Multi-Page
Share: 

Filed under:ConditionsRheumatoid Arthritis

Related Articles

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

    How a Nuclear Molecule Alarms the Immune System

    August 1, 2011

    The role of HMGB1 in the pathogenesis of lupus nephritis

    Rheumatology with Rhythm

    February 1, 2008

    The circadian rhythm offers insight into treating rheumatic diseases

    What Fat Does to Arthritis

    August 1, 2011

    The role of adipokines in the pathogenesis of rheumatic diseases

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences